摘要
目的:评价俞募配穴结合体针治疗原发性痛经的临床疗效。方法:将60例原发性痛经患者随机分为治疗组和对照组,每组30例。治疗组采用俞募配穴结合体针治疗,对照组采用口服布洛芬治疗,两组均连续治疗3个月经周期。比较两组治疗前后视觉模拟疼痛评分(VAS)、痛经症状评分、血清前列腺素F2α(PGF2α)水平及临床疗效。结果:治疗后,两组VAS疼痛评分均降低,痛经症状评分均降低,且治疗组VAS评分显著低于对照组(P<0.01),痛经症状评分显著低于对照组,组间差异具有统计学意义(P<0.01)。治疗后两组的血清炎性因子PGF2α水平均明显低于治疗前(P<0.05),且治疗组的炎性因子PGF2α水平较对照组低,差异具有统计学意义(P<0.01)。结论:俞募配穴结合体针可有效治疗原发性痛经,可通过降低体内血清炎性因子PGF2α水平,从而缓解疼痛和临床症状。
Objective: Evaluate the clinical effect of the shu-mu points combined with body acupuncture in the treatment of primary dysmenorrhea. Methods: Randomly divide the sixty patients with primary dysmenorrhea into the treatment group and the control group, with30 cases in each group. The treatment group applies to the shu-mu points combined with body acupuncture, while the control group ap-plies to the oral ibuprofen. Treat the both groups for 3 times of menstrual periods. Compare the visual analogue pain score(VAS), the dysmenorrhea symptom score, the serum prostaglandin F2α(PGF2α)levels and the clinical efficacy of the two groups of patients before and after the treatment. Results: After the treatment, the VAS and the dysmenorrhea symptom score of the two groups reduce. The VAS and the dysmenorrhea symptom score of the treatment group are significantly lower than the control group(P<0.05). The differences between the two groups has significant statistical meanings(P<0.01). After the treatment, the serum inflammatory factors level PGF2α of the two groups are significantly lower than before the treatment(P<0.05). The inflammatory factors level of the treatment group is lower than the control group, and the difference has significant statistical meanings(P<0.05). Conclusion: The combination of shu-mu points and body acupuncture can effectively treat the primary dysmenorrhea, which can relief the pain levels and the clinical symptoms of patients by reducing the serum inflammatory factor PGF2α levels in the patient’s body.
作者
林兰茹
林姗姗
徐善全
石云峰
方秀华
LIN Lan-ru;LIN Shan-shan;XU Shan-quan;SHI Yun-feng;FANG Xiu-hua(Yicheng traditional Chinese medicine hospital,Yicheng 441400 China)
出处
《内蒙古中医药》
2022年第3期82-84,共3页
Inner Mongolia Journal of Traditional Chinese Medicine
基金
湖北省中医药科研项目(项目编号ZY2019M017)。